1. Home
  2. PRKS vs ANIP Comparison

PRKS vs ANIP Comparison

Compare PRKS & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Parks & Resorts Inc.

PRKS

United Parks & Resorts Inc.

HOLD

Current Price

$36.18

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$79.03

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRKS
ANIP
Founded
1959
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
PRKS
ANIP
Price
$36.18
$79.03
Analyst Decision
Buy
Strong Buy
Analyst Count
11
6
Target Price
$50.82
$105.83
AVG Volume (30 Days)
790.2K
397.1K
Earning Date
11-06-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.27
1.67
Revenue
$1,673,396,000.00
$826,880,000.00
Revenue This Year
N/A
$44.06
Revenue Next Year
$2.24
$9.06
P/E Ratio
$11.13
$47.42
Revenue Growth
N/A
48.87
52 Week Low
$29.62
$52.74
52 Week High
$60.63
$99.50

Technical Indicators

Market Signals
Indicator
PRKS
ANIP
Relative Strength Index (RSI) 49.08 35.72
Support Level $34.21 $80.27
Resistance Level $36.60 $82.78
Average True Range (ATR) 1.04 2.21
MACD 0.38 -0.00
Stochastic Oscillator 58.05 5.23

Price Performance

Historical Comparison
PRKS
ANIP

About PRKS United Parks & Resorts Inc.

United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: